# Antitumor activity and immune-related gene expression changes following recombinant Mycobacterium smegmatis treatment in a mouse model of bladder cancer

Source: [Biological sciences : nature.com subject feeds](https://www.nature.com/articles/s41598-026-80452-x) · 2026-11-16 · Life
Page: https://themorning.science/story/antitumor-activity-and-immune-related-gene-expression-changes-following-recombin-86cde9d1b0e0790d
Kind: research · Impact: low

## In brief

- A study reports antitumour activity of recombinant Mycobacterium smegmatis in a mouse model of bladder cancer.
- The paper also examines changes in immune-related gene expression following treatment.
- The source material provided contains only the title and feed listing, so further details of methods and results are not available here.

## Why it matters

It is a preclinical mouse study, so it shows a possible route for bladder cancer immunotherapy that would still need further testing before any clinical relevance is established.

## Coverage

- [Antitumor activity and immune-related gene expression changes following recombinant Mycobacterium smegmatis treatment in a mouse model of bladder cancer](https://www.nature.com/articles/s41598-026-80452-x) — Biological sciences : nature.com subject feeds, 2026-11-16

Tags: bladder cancer, mycobacterium smegmatis, antitumour immunity, mouse model, immunotherapy

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
